IONIS PHARMACEUT reported $219M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
Arrowhead Research ARWR:US $ 103.17M 25.41M
Astellas Pharma 4503:JP 271.44B 18.61B
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Esperion Therapeutics ESPR:US $ 70.15M 3.04M
Exelixis EXEL:US $ 276.8M 14.63M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Moderna Inc MRNA:US 1.41B 119M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NOVN:VX 10.13B 319M
Omeros OMER:US $ 48.26M 4.58M
Pfizer PFE:US $ 16447M 3384M
Ptc Therapeutics PTCT:US $ 231.82M 16.65M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M